Clinical Guidelines

The Test That Could Save Patients' Bladders

Blood and urine tumor DNA monitoring may identify patients who can safely avoid cystectomy

  • By

  • February 26, 2026

  • 2 min

Share

  • 1

    ctDNA and utDNA can identify candidates for bladder preservation.

  • 2

    69% of patients with complete clinical response retained bladder integrity at 3 years.

  • 3

    Detectable ctDNA indicates higher risk of metastasis.

  • 4

    utDNA is more sensitive for detecting residual bladder disease.

  • 5

    Urine assays can reveal hidden cancer undetectable via imaging.

  • 6

    Findings lay groundwork for integrating liquid biopsies into bladder cancer management.

  • 7

    Further trials are underway for validation across larger groups.

Original Source(s)

The Test That Could Save Patients' Bladders

Blood and urine tumor DNA monitoring may identify patients who can safely avoid cystectomy

  • February 26, 2026

  • 2 min

Related Content

Insights on Sarcomas, Gastroesophageal Cancers, Peritoneal Tumors Anchor Roswell Park Presentations at SSO 2026

A Roswell Park study is shedding light on the little-understood dynamics of the tumor microenvironment (TME) in two types of rare and aggressive sarcomas — dedifferentiated liposarcomas (DDLPS) and leiomyosarcomas (LMS). 

  • by

  • February 25, 2026

  • 5 min
Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery

Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research

  • February 25, 2026

  • 2 min
What Cats Can Tell Us About Cancer

Large-scale feline sequencing study highlights diagnostic and therapeutic targets shared with human cancers

  • February 25, 2026

  • 2 min